Colinz Laboratories Ltd.
| BSE: 531210 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE923C01011 |
| BSE 00:00 | 18 Sep | 5.97 |
0 (0.00%) |
OPEN
5.97 |
HIGH
5.98 |
LOW
5.97 |
| NSE 05:30 | 01 Jan | Colinz Laboratories Ltd |
| OPEN | 5.97 |
| PREVIOUS CLOSE | 5.97 |
| VOLUME | 201 |
| 52-Week high | 10.22 |
| 52-Week low | 5.97 |
| P/E | 20.59 |
| Mkt Cap.(Rs cr) | 3 |
| Buy Price | 5.97 |
| Buy Qty | 100.00 |
| Sell Price | 6.59 |
| Sell Qty | 44.00 |
Colinz Laboratories Ltd. (COLINZLABS) - News Sector
-
New Covid-19 drugs provide additional fuel as Cipla fires on all cylinders
2.23 am | 19 Sep 2020 | Business Standard
Firm domestic sales and positive outlook in the US point to robust earnings
-
Sensex ends 134 pts lower, Nifty settles at 11,505; Nifty Pharma jumps 5%
4.23 pm | 18 Sep 2020 | Business Standard
All that happened in the markets today
-
Dr Reddy's reclaims spot as India's 2nd most valuable pharma company
2.47 pm | 18 Sep 2020 | Business Standard
At 02:17 pm, Dr Reddy's Labs market cap stood at Rs 90,348 crore while that of Divi's Laboratories stood at Rs 89,119 crore, BSE data show
-
Dr Reddy's reclaims spot as India's 2nd most valuable pharma company
2.47 pm | 18 Sep 2020 | Business Standard
At 02:17 pm, Dr Reddy's Labs market cap stood at Rs 90,348 crore while that of Divi's Laboratories stood at Rs 89,119 crore, BSE data show
-
Dr Reddy's reclaims spot as India's 2nd most valuable pharma company
2.47 pm | 18 Sep 2020 | Business Standard
At 02:17 pm, Dr Reddy's Labs market cap stood at Rs 90,348 crore while that of Divi's Laboratories stood at Rs 89,119 crore, BSE data show
-
344 stocks in Nifty 500 index are indicating a bullish trend, shows MACD
12.43 pm | 18 Sep 2020 | Business Standard
Out of these 344 stocks, 211 stocks are trading with a positive crossover. This scenario indicates that over 50 per cent stocks are signalling positiv...
-
344 stocks in Nifty 500 index are indicating a bullish trend, shows MACD
12.43 pm | 18 Sep 2020 | Business Standard
Out of these 344 stocks, 211 stocks are trading with a positive crossover. This scenario indicates that over 50 per cent stocks are signalling positiv...
-
BSE Healthcare index hits record high; Laurus Labs, Dr Reddy's at new highs
10.17 am | 18 Sep 2020 | Business Standard
Lupin, Stride Pharma, Neuland Labs, Lincoln Pharma, and Hikal hit their respective 52-week highs on the BSE
-
BSE Healthcare index hits record high; Laurus Labs, Dr Reddy's at new highs
10.17 am | 18 Sep 2020 | Business Standard
Lupin, Stride Pharma, Neuland Labs, Lincoln Pharma, and Hikal hit their respective 52-week highs on the BSE
-
BSE Healthcare index hits record high; Laurus Labs, Dr Reddy's at new highs
10.17 am | 18 Sep 2020 | Business Standard
Lupin, Stride Pharma, Neuland Labs, Lincoln Pharma, and Hikal hit their respective 52-week highs on the BSE
-
BSE Healthcare index hits record high; Laurus Labs, Dr Reddy's at new highs
10.17 am | 18 Sep 2020 | Business Standard
Lupin, Stride Pharma, Neuland Labs, Lincoln Pharma, and Hikal hit their respective 52-week highs on the BSE
-
BSE Healthcare index hits record high; Laurus Labs, Dr Reddy's at new highs
10.17 am | 18 Sep 2020 | Business Standard
Lupin, Stride Pharma, Neuland Labs, Lincoln Pharma, and Hikal hit their respective 52-week highs on the BSE
-
Covid-19: Mass production of Sputnik V likely to take several months
1.25 am | 18 Sep 2020 | Business Standard
Vaccine makers here feel the Sputnik is still a work in progress and needs time to develop
-
Strong growth in pharmacy business saves the day for Apollo Hospitals
6.23 pm | 17 Sep 2020 | Business Standard
Hospital business, though is recovering and along with fast-growing pharmacy segment and foray into online services should add to earnings, valuations
-
Hikal shares advance 12%, hit 52-week high on growth prospects
3.30 pm | 17 Sep 2020 | Business Standard
For the April-June quarter (Q1FY21), Hikal reported a 25 per cent year-on-year (YoY) decline in its consolidated profit before tax (PBT) at Rs 27.50 c...
-
Laurus Labs hits fresh record high on expectation of strong earnings
12.12 pm | 17 Sep 2020 | Business Standard
Analysts believe Laurus is well poised to follow the success story of some leading CDMO players backed by strong chemistry and integrated model
-
Dr Reddy's, Biocon, Torrent Pharma: What charts indicate for these stocks
12.01 pm | 17 Sep 2020 | Business Standard
The next upside for Nifty Pharma is located above the resistance of 12,100 levels.
-
Dr Reddy's, Biocon, Torrent Pharma: What charts indicate for these stocks
12.01 pm | 17 Sep 2020 | Business Standard
The next upside for Nifty Pharma is located above the resistance of 12,100 levels.
-
Dr Reddy's, Biocon, Torrent Pharma: What charts indicate for these stocks
12.01 pm | 17 Sep 2020 | Business Standard
The next upside for Nifty Pharma is located above the resistance of 12,100 levels.
-
Dr Reddy's Labs gains for second straight day on Covid vaccine deal
10.49 am | 17 Sep 2020 | Business Standard
Upon regulatory approval in India, RDIF shall supply to Dr. Reddy's 100 million doses of the vaccine
Quick Links for Colinz Laboratories:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
